Compassionate Use

Written by Sylvia Schuepbach

Early Access Program: Access to innovative medicines for patients

A pharmaceutical company with a focus on clinical research implemented a compassionate use program at the request of the medical profession. We drew up the necessary contracts for this, tailored to the specific requirements of the intended treatment and the needs of the doctors involved. As a result, patients were able to benefit from a new treatment option at an early stage.

Sylvia Schuepbach
Back

Pharmaceutical marketing on the Internet
Next

Experimental therapy